Global Varicella Attenuated Live Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

The Varicella Attenuated Live Vaccine, commonly known as the Varicella vaccine or chickenpox vaccine, is a preventive immunization designed to protect against the varicella-zoster virus, which causes chickenpox. This vaccine is composed of weakened or attenuated live viruses that stimulate the immune system to produce an immune response without causing the disease itself. Administered through a series of doses, the Varicella vaccine is highly effective in preventing chickenpox and reducing the severity of the illness in case of exposure. It is a crucial component of routine childhood immunization schedules in many countries, contributing to the control and prevention of chickenpox outbreaks and associated complications. Additionally, the vaccine has been instrumental in reducing the incidence of herpes zoster (shingles), which can occur later in life as a reactivation of the varicella-zoster virus.

According to DIResearch's in-depth investigation and research, the global Varicella Attenuated Live Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Varicella Attenuated Live Vaccine include Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech, Changchun Changsheng Life Sciences Limited etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Varicella Attenuated Live Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Varicella Attenuated Live Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Varicella Attenuated Live Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Varicella Attenuated Live Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Varicella Attenuated Live Vaccine Include:

Merck

BCHT

Shanghai Institute

GSK

Keygen

Green Cross

Biken

Shanghai Rongsheng Biotech

Changchun Changsheng Life Sciences Limited

Varicella Attenuated Live Vaccine Product Segment Include:

Monovalent Vaccine

Combination Vaccine

Varicella Attenuated Live Vaccine Product Application Include:

Kids Injection

Adults Injection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Varicella Attenuated Live Vaccine Industry PESTEL Analysis

Chapter 3: Global Varicella Attenuated Live Vaccine Industry Porter's Five Forces Analysis

Chapter 4: Global Varicella Attenuated Live Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Varicella Attenuated Live Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Varicella Attenuated Live Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Varicella Attenuated Live Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Varicella Attenuated Live Vaccine Product by Type

1.2.1 Global Varicella Attenuated Live Vaccine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Monovalent Vaccine

1.2.3 Combination Vaccine

1.3 Varicella Attenuated Live Vaccine Product by Application

1.3.1 Global Varicella Attenuated Live Vaccine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Kids Injection

1.3.3 Adults Injection

1.4 Global Varicella Attenuated Live Vaccine Market Revenue and Sales Analysis

1.4.1 Global Varicella Attenuated Live Vaccine Market Size Analysis (2019-2030)

1.4.2 Global Varicella Attenuated Live Vaccine Market Sales Analysis (2019-2030)

1.4.3 Global Varicella Attenuated Live Vaccine Market Sales Price Trend Analysis (2019-2030)

1.5 Varicella Attenuated Live Vaccine Market Development Status and Trends

1.5.1 Varicella Attenuated Live Vaccine Industry Development Status Analysis

1.5.2 Varicella Attenuated Live Vaccine Industry Development Trends Analysis

2 Varicella Attenuated Live Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Varicella Attenuated Live Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Varicella Attenuated Live Vaccine Market Analysis by Regions

4.1 Varicella Attenuated Live Vaccine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2025-2030)

4.3 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis (2019-2030)

4.3.1 Global Varicella Attenuated Live Vaccine Sales and Market Share by Region (2019-2024)

4.3.2 Global Varicella Attenuated Live Vaccine Sales Forecast by Region (2025-2030)

4.4 Global Varicella Attenuated Live Vaccine Sales Price Trend Analysis (2019-2030)

5 Global Varicella Attenuated Live Vaccine Market Size by Type and Application

5.1 Global Varicella Attenuated Live Vaccine Market Size by Type

5.1.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Varicella Attenuated Live Vaccine Market Size by Application

5.2.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Varicella Attenuated Live Vaccine Market Size by Type

6.3.1 North America Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

6.3.2 North America Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

6.4 North America Varicella Attenuated Live Vaccine Market Size by Application

6.4.1 North America Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

6.4.2 North America Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

6.5 North America Varicella Attenuated Live Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Varicella Attenuated Live Vaccine Market Size by Type

7.3.1 Europe Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

7.3.2 Europe Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

7.4 Europe Varicella Attenuated Live Vaccine Market Size by Application

7.4.1 Europe Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

7.4.2 ? Europe Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

7.5 Europe Varicella Attenuated Live Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Varicella Attenuated Live Vaccine Market Size by Type

8.3.1 China Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

8.3.2 China Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

8.4 China Varicella Attenuated Live Vaccine Market Size by Application

8.4.1 China Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

8.4.2 China Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Type

9.3.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

9.4 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Application

9.4.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

9.5 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Varicella Attenuated Live Vaccine Market Size by Type

10.3.1 Latin America Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

10.3.2 Latin America Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

10.4 Latin America Varicella Attenuated Live Vaccine Market Size by Application

10.4.1 Latin America Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

10.4.2 Latin America Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

10.5 Latin America Varicella Attenuated Live Vaccine Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Type

11.3.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Type (2019-2030)

11.3.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)

11.4 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Application

11.4.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Application (2019-2030)

11.4.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)

11.5 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Varicella Attenuated Live Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Varicella Attenuated Live Vaccine Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Varicella Attenuated Live Vaccine Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Varicella Attenuated Live Vaccine Average Sales Price by Manufacturers (2020-2024)

12.2 Varicella Attenuated Live Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Varicella Attenuated Live Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Merck

13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Merck Varicella Attenuated Live Vaccine Product Portfolio

13.1.3 Merck Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 BCHT

13.2.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 BCHT Varicella Attenuated Live Vaccine Product Portfolio

13.2.3 BCHT Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Shanghai Institute

13.3.1 Shanghai Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Shanghai Institute Varicella Attenuated Live Vaccine Product Portfolio

13.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 GSK

13.4.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 GSK Varicella Attenuated Live Vaccine Product Portfolio

13.4.3 GSK Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Keygen

13.5.1 Keygen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Keygen Varicella Attenuated Live Vaccine Product Portfolio

13.5.3 Keygen Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Green Cross

13.6.1 Green Cross Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Green Cross Varicella Attenuated Live Vaccine Product Portfolio

13.6.3 Green Cross Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Biken

13.7.1 Biken Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Biken Varicella Attenuated Live Vaccine Product Portfolio

13.7.3 Biken Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Shanghai Rongsheng Biotech

13.8.1 Shanghai Rongsheng Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Portfolio

13.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Changchun Changsheng Life Sciences Limited

13.9.1 Changchun Changsheng Life Sciences Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Portfolio

13.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Varicella Attenuated Live Vaccine Industry Chain Analysis

14.2 Varicella Attenuated Live Vaccine Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Varicella Attenuated Live Vaccine Typical Downstream Customers

14.4 Varicella Attenuated Live Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support